IMBdx (XKRX:461030) EBIT per Share : ₩-458.15 (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is IMBdx EBIT per Share?

IMBdx's EBIT per Share for the three months ended in Mar. 2024 was ₩-211.06. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-458.15.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for IMBdx's EBIT per Share or its related term are showing as below:

XKRX:461030's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 4.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

IMBdx's EBIT for the three months ended in Mar. 2024 was ₩-2,953 Mil.

IMBdx EBIT per Share Historical Data

The historical data trend for IMBdx's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx EBIT per Share Chart

IMBdx Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

-8,520.19

-1,697.13

-1,196.79

IMBdx Quarterly Data
	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial			-301.98	-575.23	-	-247.09	-211.06

IMBdx EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

IMBdx's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9472.608	/	7.915
=	-1,196.79

IMBdx's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2953.39	/	13.993
=	-211.06

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-458.15

IMBdx (XKRX:461030) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

IMBdx EBIT per Share Related Terms

Thank you for viewing the detailed overview of IMBdx's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

IMBdx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506

Website

https://www.imbdx.com

IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines